PALVELLA THERAPEUTICS, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Goin Kathleen | Chief Operating Officer | Sale | 4,302 | $96.47 | $415,014 | — | Dec 17, 2025 |
| Goin Kathleen | Chief Operating Officer | Option Exercise | 2,148 | $9.08 | $19,504 | 4,302 | Nov 19, 2025 |
| JENKINS GEORGE M | — | Purchase | 2,490 | $20.27 | $50,472 | 13,516 | Apr 9, 2025 |
| JENKINS GEORGE M | — | Purchase | 4,000 | $12.93 | $51,720 | 180,671 | Dec 18, 2024 |
| BVF I GP LLC | — | Other | 174,958 | — | — | 282,223 | Dec 13, 2024 |
| GERAGHTY JAMES A | — | Disposition | 1 | $0.01 | $0 | — | Dec 12, 2024 |
| ADAR1 Capital Management, LLC | — | Purchase | 2,243 | $15.88 | $35,619 | 129,574 | Aug 9, 2024 |
| GERAGHTY JAMES A | — | Purchase | 1 | $1.00 | $1 | 1 | Aug 7, 2024 |
| KIRITSY CHRISTOPHER P | — | Purchase | 10,000 | $0.85 | $8,500 | 20,000 | May 25, 2023 |
| Demuth Tim | Chief Medical Officer | Purchase | 6,000 | $1.71 | $10,260 | 6,000 | May 13, 2022 |
| Olwill Shane | Chief Development Officer | Sale | 9,200 | $5.00 | $46,000 | 33,838 | Aug 30, 2021 |
| Aquilo Capital Management, LLC | — | Sale | 1,900,000 | $2.95 | $5,605,000 | 3,675,530 | Jul 21, 2020 |
| BVF Partners OS Ltd. | — | Sale | 25,720 | $4.50 | $115,740 | 2,233,074 | Sep 6, 2019 |
| BIOTECHNOLOGY VALUE FUND L P | — | Other | 2,143,000 | — | — | 772,324 | Jan 30, 2019 |
| KIRITSY CHRISTOPHER P | — | Purchase | 5,000 | $5.11 | $25,550 | 10,000 | Sep 14, 2018 |
| GERAGHTY JAMES A | — | Purchase | 10,000 | $5.75 | $57,500 | 20,000 | May 15, 2018 |
| ORBIMED ADVISORS LLC | — | Sale | 989,600 | $6.35 | $6,283,960 | 4,511,130 | Apr 30, 2018 |
| OrbiMed Capital GP III LLC | — | Sale | 75 | $8.98 | $674 | 49,270 | Feb 13, 2018 |
| ISALY SAMUEL D | — | Sale | 1,693,492 | $7.35 | $12,447,166 | 5,500,730 | Jan 3, 2018 |
| OrbiMed Capital GP III LLC | — | Option Exercise | 10,180 | $1.62 | $16,492 | 7,252,241 | Dec 18, 2017 |
| Reine Allan | See Remarks | Purchase | 45,000 | $4.79 | $215,550 | 45,000 | Aug 17, 2017 |
| GERAGHTY JAMES A | — | Purchase | 10,000 | $4.82 | $48,200 | 10,000 | Aug 17, 2017 |
| KIRITSY CHRISTOPHER P | — | Option Exercise | 5,000 | $1.59 | $7,950 | 5,000 | Apr 21, 2017 |
| Matis Louis | SVP, Chief Development Officer | Purchase | 7,915 | $1.71 | $13,535 | 10,000 | Jun 13, 2016 |
| Yoder Stephen S. | President and CEO | Purchase | 6,000 | $1.68 | $10,080 | 6,000 | Jun 13, 2016 |
| DEPTULA-HICKS DARLENE M | SVP, Chief Financial Officer | Purchase | 5,000 | $1.66 | $8,300 | 5,000 | Jun 13, 2016 |
| Khuong Chau Quang | — | Purchase | 495,283 | $2.75 | $1,362,028 | 7,194,222 | Jul 6, 2015 |
| ISALY SAMUEL D | — | Purchase | 495,283 | $2.75 | $1,362,028 | 7,194,222 | Jul 6, 2015 |